Top Ad

Glucagon

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

Category: Critical Care

Glucagon is a life-saving hormone used to treat severe hypoglycemia and as a diagnostic aid in gastrointestinal procedures. It is available in 1 mg lyophilized powder for IM, IV, or SC injection and is marketed under brands such as Glucagen® and Gvoke® in the US, and Glucagen® Hypokit in the EU. Glucagon rapidly increases blood glucose levels and is essential in emergency kits and hospital crash carts. Pharma B2B platforms enable bulk sourcing of GMP-compliant Glucagon formulations, offering consistent quality, reliable supply chains, and global regulatory support for healthcare institutions, emergency responders, and hospital procurement teams.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View More Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View More Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View More Get Enquiry
Nitroprusside

Strength: 50 mg/2 mL vial

Form: Intravenous (IV) injection

Reference Brands: Nitropress®(US), Nitroprussiat Ferrlecit®(EU)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.